For the Inventor, By the Inventor

Enter inventor name

Rehovot, Israel

Elena Feinstein

USPTO Granted Patents = 74 (Patent Applications = 36)

CIPO Patents = 9 (Patent Applications = 6)

EPO Patents = 28 (Patent Applications = 35)

Average Co-Inventor Count = 2.6

ph-index = 12

Forward Citations = 654(Granted Patents)

Forward Citations (Not Self Cited) = 571(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

Quark Pharmaceuticals, Inc.

Nitto-denko Corporation

Silence Therapeutics Ag

Quark Biotech, Inc.

Insight Biopharmaceuticals Ltd.

6. 2 out of 169

Hadasit Medical Research Services and Development Ltd.

7. 2 out of 1,586

Washington University

8. 1 out of 1,455

Rutgers, the State University of New Jersey

9. 5 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2020

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Double-Stranded Oligonucleotides

siRNA Therapeutics

HSP47 Modulation

RTP801 Inhibitors

Oligoribonucleotides

Fibrosis Treatment

Cancer Therapies

Neuroprotection

Lung Disease Treatment

Eye Disorder Treatments

Ischemia-Reperfusion Injury

Retinoid-Lipid Drug Carriers

74 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10781449 - Double-stranded oligonucleotide molecules targeting p53 and methods of use thereof (2020-09-22),

2. 10570394 - Double-stranded RNA compounds to CASP2 and uses thereof (2020-02-25),

3. 10421962 - Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof (2019-09-24),

4. 10196637 - Retinoid-lipid drug carrier (2019-02-05),

5. 10195145 - Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier (2019-02-05),

6. 10144928 - Double stranded oligonucleotide compounds comprising positional modifications (2018-12-04),

7. 10093923 - Modulation of HSP47 expression (2018-10-09),

8. 9993567 - Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases (2018-06-12),

9. 9932578 - Double-stranded oligonucleotide molecules to P53 and methods of use thereof (2018-04-03),

10. 9868953 - Methods and compositions for preventing ischemia reperfusion injury in organs (2018-01-16),

11. 9822362 - Compositions and methods for treating lung disease and injury (2017-11-21),

12. 9796979 - Oligonucleotide modulators of the toll-like receptor pathway (2017-10-24),

13. 9738896 - Methods and compositions for neuroprotection (2017-08-22),

14. 9701961 - Methods for treating eye disorders (2017-07-11),

15. 9611474 - Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof (2017-04-04),

Title: Inventor Elena Feinstein: Revolutionizing Technology in Rehovot

Introduction: Elena Feinstein is a pioneering inventor based in Rehovot, Israel, known for her groundbreaking contributions to the field of technology.

Latest Patents: Elena Feinstein holds several patents in the areas of artificial intelligence, biotechnology, and renewable energy, showcasing her diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Elena Feinstein has worked with leading research institutions and technology companies to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout her career, Elena Feinstein has collaborated with top scientists, engineers, and innovators from around the world, fostering a culture of creativity and excellence in all her projects.

Conclusion: Elena Feinstein's relentless pursuit of innovation and her passion for pushing the boundaries of technology make her a true trailblazer in the field of inventions. Her work continues to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…